René Bernards
机构：The Netherlands Cancer Institute, Shanghai Cancer Institute, Oncode Institute · ORCID：0000-0001-8677-3423
发表论文 910 篇 · 总被引 79427 次 · h-index 113
代表论文
- Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial (2025 · ESMO Open · 被引 1)
- A Counterintuitive Approach to Cancer Therapy (2026 · Cancer Discovery)
- Inhibition of mitochondrial protein translation sensitizes tumor cells to death receptor 5 agonistic antibody (2026 · FEBS Journal)
- XPO1 inhibition induces NCOR1-Dependent oxidative stress to suppress hepatocellular carcinoma (2026 · Cell chemical biology)
- Table S2 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy (2026)
- Figure S8 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy (2026)